E. Maillard

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

Jean‐Pierre Pignon, Aurélie Le Maître, E. Maillard et al. · Radiotherapy and Oncology · 2009 · 3K citations

Neck Cancer, Medicine, Randomised Trials +8

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901

C. Mariette, Laëtitia Dahan, F. Mornex et al. · Journal of Clinical Oncology · 2014 · 597 citations

Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study

Rosine Guimbaud, Christophe Louvet, Pauline Ries et al. · Journal of Clinical Oncology · 2014 · 256 citations

Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma

Franck Bonnetain, Laëtitia Dahan, E. Maillard et al. · European Journal of Cancer · 2010 · 107 citations

Quality Of Life, Surgical Oncology, Definitive Quality +8

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)

Thomas Aparicio, Sandrine Lavau‐Denès, Jean–Marc Phelip et al. · Annals of Oncology · 2015 · 104 citations · Full text

Elderly Patients, Gastrointestinal Oncology, Medicine +8